SEC 13F Intelligence

Dsm Capital Partners LLC / BSX

Dsm Capital Partners LLC’s Boston Scientific Corp Position

Does Dsm Capital Partners LLC own Boston Scientific Corp (BSX)? Yes — 564.3K shares worth $35M (+0.63% of its 13F portfolio) as of Q1 2026, up from 4.7K shares the prior filed quarter.

Position Value
$35M
Q1 2026
Shares
564.3K
% of Portfolio
+0.63%
Quarters Held
24
currently held

Position History BSX

Reported value by quarter
Q4 ’19: $103MQ4 ’19Q1 ’20: $118MQ2 ’20: $72MQ3 ’20: $96MQ3 ’20Q4 ’20: $108MQ1 ’21: $122MQ2 ’21: $155MQ2 ’21Q3 ’21: $179MQ4 ’21: $164MQ1 ’22: $223MQ1 ’22Q2 ’22: $197MQ3 ’22: $217MQ4 ’22: $231,364Q4 ’22Q1 ’23: $183MQ2 ’23: $135MQ3 ’23: $126MQ3 ’23Q4 ’23: $164MQ1 ’24: $149MQ2 ’24: $101,961Q2 ’24Q3 ’24: $110,951Q2 ’25: $306,978Q3 ’25: $388,275Q3 ’25Q4 ’25: $450,433Q1 ’26: $35Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026564.3K$35M+0.63%
Q4 20254.7K$450,433+0.01%
Q3 20254.0K$388,275+0.01%
Q2 20252.9K$306,9780.00%
Q3 20241.3K$110,9510.00%
Q2 20241.3K$101,9610.00%
Q1 20242.17M$149M+2.03%
Q4 20232.84M$164M+2.51%
Q3 20232.39M$126M+2.13%
Q2 20232.49M$135M+2.18%
Q1 20233.65M$183M+2.99%
Q4 20225.00M$231,364+3.85%
Q3 20225.59M$217M+3.67%
Q2 20225.30M$197M+3.31%
Q1 20225.03M$223M+2.98%
Q4 20213.85M$164M+1.72%
Q3 20214.13M$179M+1.86%
Q2 20213.62M$155M+1.49%
Q1 20213.16M$122M+1.30%
Q4 20202.99M$108M+1.15%
Q3 20202.51M$96M+1.07%
Q2 20202.06M$72M+0.86%
Q1 20203.62M$118M+1.79%
Q4 20192.28M$103M+1.37%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsm Capital Partners LLC’s full portfolio or all institutional holders of BSX.